Animal Reproduction Science, Journal Year: 2024, Volume and Issue: 272, P. 107653 - 107653
Published: Nov. 26, 2024
Language: Английский
Animal Reproduction Science, Journal Year: 2024, Volume and Issue: 272, P. 107653 - 107653
Published: Nov. 26, 2024
Language: Английский
Toxicology and Applied Pharmacology, Journal Year: 2025, Volume and Issue: 495, P. 117226 - 117226
Published: Jan. 7, 2025
Language: Английский
Citations
0South African Journal of Botany, Journal Year: 2025, Volume and Issue: 177, P. 729 - 741
Published: Jan. 10, 2025
Language: Английский
Citations
0European Journal of Pharmacology, Journal Year: 2025, Volume and Issue: unknown, P. 177518 - 177518
Published: March 1, 2025
Language: Английский
Citations
0Pharmaceuticals, Journal Year: 2025, Volume and Issue: 18(4), P. 535 - 535
Published: April 6, 2025
Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness in older adults. Its pathogenesis involves multiple factors, including aging, environmental influences, genetic predisposition, oxidative stress, metabolic dysfunction, immune dysregulation. Currently, AMD treatment focuses primarily on wet AMD, managed through repeated intravitreal injections anti-vascular endothelial growth factor (VEGF) therapies. While anti-VEGF agents represent major breakthrough care, may lead to incomplete responses or resistance some patients, carry risk progressive fibrosis. Artemisinin (ART) its derivatives, originally developed as antimalarial drugs, exhibit broad spectrum pleiotropic activities beyond their established use, anti-inflammatory, anti-angiogenic, antioxidant, anti-fibrotic, mitochondrial regulatory, lipid metabolic, immunosuppressive effects. These properties position ART promising therapeutic candidate for AMD. A growing interest ART-based therapies has emerged recent years, with numerous studies demonstrating potential benefits. However, no comprehensive review systematically summarized the specific roles derivatives treatment. This paper aims fill knowledge gap by synthesizing efficacy molecular mechanisms thereby providing foundation future investigations.
Language: Английский
Citations
0Phytomedicine, Journal Year: 2024, Volume and Issue: 134, P. 155962 - 155962
Published: Aug. 15, 2024
Vasculogenic mimicry (VM) is a novel model for supplying blood to multiple tumors, including gastric cancer (GC), and potential target its treatment. Dihydroartemisinin (DHA) natural antitumor substance that inhibits the progression of tumors in many ways. The research aimed evaluate impact DHA on VM formation mechanisms. IC50 DHA, DHA's effect proliferation, invasion, migration GC cells both cell animal models were determined through wound healing, MTT, EdU, colony formation, Transwell assays. Genomics was employed identify genes related inhibition analyze their relationship formation. qRT‒PCR western blot (WB) analysis carried out changes protein mRNA levels after treatment VM-associated biomarkers blocking gene-related pathways. mechanism by which elucidated vivo. reduced inhibited A total 220 DEGs identified DHA-treated HGC-27 cells. Among 146 downregulated genes, fibroblast growth Factor 2 (FGF2) most closely associated with angiogenesis VM. level FGF2 tissues markedly greater than lacking tissues. Treatment or FGFR1 blockade suppressed VM-related biomarker proteins. tumor reducing xenograft mouse models. Per our knowledge, this first study demonstrate inhibitory VM, providing strategy GC.
Language: Английский
Citations
3Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14
Published: July 16, 2024
Hepatocellular carcinoma is one of the common malignant tumors digestive tract, which seriously threatens life patients due to its high incidence rate, strong invasion, metastasis, and prognosis. At present, main methods for preventing treating HCC include medication, surgery, intervention, but frequently encounter with specific adverse reactions or side effects. Many Traditional Chinese medicine can improve liver function, reduce cancer recurrence have unique advantages in treatment because their acting mode multi-target, multi-pathway, multi-component, multi-level. Sesquiterpenoids, a class natural products are widely present nature exhibit good anti-tumor activity, many them possess potential HCC. This article reviewed activities, resources, pharmacological mechanism sesquiterpenoids against HCC, providing theoretical basis prevention comprehensive understanding development new clinical drugs.
Language: Английский
Citations
2Phytochemistry, Journal Year: 2024, Volume and Issue: 230, P. 114317 - 114317
Published: Nov. 7, 2024
Language: Английский
Citations
2Antibiotics, Journal Year: 2024, Volume and Issue: 13(4), P. 310 - 310
Published: March 28, 2024
This study aimed to assess the antifungal and antibiofilm efficacy of artemisinin against Candida (C.) species, analyze its impact on gene expression levels within C. albicans biofilms, investigate molecular interactions through docking. The a variety including fluconazole-resistant -susceptible was evaluated by microdilution method. effect biofilm formation investigated MTT FESEM. mRNA genes related analyzed qRT-PCR. In addition, docking analysis used understand interaction between at level with RAS1-cAMP-EFG1 EFG1-regulated genes. Artemisinin showed higher sensitivity non-albicans strains. Furthermore, strongly inhibitory biofilms 640 µg/mL. downregulated adhesion-related ALS3, HWP1, ECE1, hyphal development UME6 HGC1, CAMP-dependent protein kinase regulators CYR1, RAS1, EFG1. revealed that EFG1 had highest affinity, followed UME6. FESEM fluconazole- artemisinin-treated groups exhibited reduced network, unusual surface bulges, pores cell surfaces. Our suggests may have potential remarkable activity significantly suppressing adhesion key proteins involved in formation, such as
Language: Английский
Citations
1Molecules, Journal Year: 2024, Volume and Issue: 29(17), P. 4193 - 4193
Published: Sept. 4, 2024
The emergence of natural products has provided extremely valuable references for the treatment various diseases. Cucurbitacin B, a tetracyclic triterpenoid compound isolated from cucurbitaceae and other plants, is most abundant member cucurbitin family exhibits wide range biological activities, including anti-inflammatory, anti-cancer, even agricultural applications. Due to its high toxicity narrow therapeutic window, structural modification dosage form development are necessary address these issues with cucurbitacin B. This paper reviews recent research progress in pharmacological action, modification, application review aims enhance understanding advancements this field provide constructive suggestions further on
Language: Английский
Citations
1Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: July 30, 2024
Language: Английский
Citations
0